Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 3 × Warts × Cantharidin × Clear all

Phase

Phase 4 2 Phase 3 1 Phase 2 1

Status

Not yet recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Interventions

N-phenylacetoaminomethylene-DL-p-nitrophenylalanine 2 2-Propanol 2 methyl 5-aminolevulinate 1 Zinc Sulfate 1 Vaccination 1 VP-102 1 Tuberculin 1 Photochemotherapy 1 PRA1 protein, Candida albicans 1 Exercise 1 Cantharidin 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT07457918 2026-03-09

COVE-4

Verrica Pharmaceuticals Inc.

Phase 3 Not yet recruiting

Warts

Data powered by HemOnc (CC BY 4.0) Colophon ⚡